Performance
Trailing returns
| 1 day | +0.42% |
| |||
| 1 week | +0.95% |
| |||
| 4 week | +3.12% |
| |||
| 3 month | +6.18% |
| |||
| YTD | +13.57% |
| |||
| 1 year | +20.38% |
| |||
| 3 years* | +6.86% |
| |||
| 5 years* | - | ||||
| *annualised | |||||
| Best 3-month return | +10.52% | |
| Worst 3-month return | -2.52% |
Morningstar statistics
Morningstar category: Alt - Long/Short Equity - Europe
Morningstar style Learn more
| Large | |||
| Mid | |||
| Small | |||
| Value | Blend | Growth |
Key statistics
| Total assets | 7.66M | |
| Front load | 5.00% | |
| Deferred load | - | |
| Expense ratio | - | |
| Management fee | 1.00% | |
| Fund family | Henderson Investment Funds Ltd. |
Asset allocation
| Cash | 42.60% | |
| Stocks | 60.87% | |
| Bonds | 0.00% | |
| Other | -3.47% |
Purchase information
| Initial | �500,000 | |
| Additional | �250 |
1.34+0.01(0.42%)
May 20, 4:00pm BST
Description
The fund�s objective is to achieve a positive absolute return over the long-term regardless of market conditions, by taking long and short positions primarily in equities or equity related derivative contracts of: companies having their registered office in Europe (including United Kingdom); and companies that do not have their registered office in Europe (including United Kingdom) but either (i) carry out a predominant proportion of their business activity in these markets, or (ii) are holding companies which predominantly own companies with registered offices in Europe (including United Kingdom), although all or a substantial proportion of the physical assets of the Fund may at any time consist of cash, near cash, deposits and/or money market instruments. The Fund will invest in companies of any market capitalisation.
Asset manager:
John Bennett (Started: Jan 31, 2011)
John Bennett (Started: Jan 31, 2011)
Advisor Company:
Gartmore Investment Ltd.
Gartmore Investment Ltd.
Risk
| 1 year | 3 years | 5 years | 10 years | ||
| Alpha* | - | - | - | - | |
| Beta* | - | - | - | - | |
| Mean annual return | 0.85 | 0.52 | - | - | |
| R-squared* | - | - | - | - | |
| Standard deviation | 7.34 | 7.70 | - | - | |
| Sharpe ratio | 1.36 | 0.73 | - | - | |
| * Against standard index | |||||
Top 10 holdings
| Security | Net Assets | |
| Eux Dax Index Mar13 Future (Exp 15/03/2013) | 12.99% | |
| Eop Cac40 10 Euro Feb13 Future (Exp 15/02/2013) | 12.85% | |
| Lif Ftse 100 Index Mar13 Future (Exp 15/03/2013) | 11.37% | |
| Novartis AG (NVSEF) | 6.84% | |
| Roche Holding AG (RHHVF) | 6.78% | |
| Reed Elsevier NV (REN) | 4.01% | |
| Nestle SA (NSRGF) | 3.46% | |
| Bic (BB) | 3.06% | |
| Bayer AG (BAYN) | 2.54% | |
| Henkel AG & Co KGaA (HEN3) | 2.52% |